How to Help Your Patients Find Ezetimibe in Stock: A Provider's Guide

For most clinicians, a patient calling to say their pharmacy is out of ezetimibe triggers a familiar administrative spiral: call the pharmacy, find alternatives, consider a prior authorization — all before seeing the next patient. This guide gives you a streamlined, practical workflow to resolve ezetimibe access issues efficiently, while protecting continuity of care.

Step 1: Assess Urgency Based on Patient Risk Profile

Before taking action, quickly classify the patient's cardiovascular risk:

Very high risk (post-ACS, HoFH, LDL target <55 mg/dL): Act within 24-48 hours. Prioritize finding the existing prescription or prescribing a bridge therapy.

High risk (ASCVD, LDL target <70 mg/dL): Act within 3-5 days. Missing a week of ezetimibe at this risk level is not immediately dangerous but warrants prompt resolution.

Primary prevention, moderate risk: A brief gap in therapy is unlikely to be clinically significant. Direct the patient to find stock at a nearby pharmacy or try mail-order.

Step 2: Try to Find the Existing Prescription First

A prescription change (with its associated PA risk and administrative burden) should be a last resort if the issue is simply a local stock gap. Before changing therapy:

Direct the patient to medfinder, which calls pharmacies near the patient to identify which ones have ezetimibe in stock — without requiring any prescription changes.

Have your staff call 1-2 major chain pharmacies in the patient's ZIP code. CVS, Walgreens, Walmart, and Costco pharmacy tend to have the most reliable ezetimibe inventory.

Ask if the patient's current pharmacy can special-order from an alternate wholesaler — ezetimibe's multi-manufacturer supply chain usually allows substitution within 1-2 business days.

If the patient has insurance with a preferred mail-order pharmacy, e-prescribe a 90-day supply. Most mail-order pharmacies maintain larger inventories than retail.

Step 3: If Medication Must Be Changed, Choose the Right Bridge

If ezetimibe cannot be sourced within a clinically appropriate timeframe, consider these bridging options:

Patient on ezetimibe + moderate statin, no statin intolerance: Temporarily intensify the statin to high-intensity (atorvastatin 40-80 mg or rosuvastatin 20-40 mg). This achieves a similar LDL reduction to the ezetimibe combination with no PA required.

Statin-intolerant patient on ezetimibe monotherapy: Bempedoic acid (Nexletol, 180 mg daily) reduces LDL by 15-25% via a mechanism complementary to ezetimibe. It does not cause muscle side effects in most patients and is available as a brand (no generic yet). Manufacturer copay assistance programs can reduce out-of-pocket cost.

Very high-risk patient not at LDL goal: Submit a PA for a PCSK9 inhibitor. Document the shortage, prior ezetimibe use, LDL level, and ASCVD risk category. Some payers accept shortage documentation as justification for bypassing step therapy.

Proactive Practice-Level Strategies

Rather than addressing ezetimibe access issues reactively, consider these proactive strategies:

Prescribe 90-day supplies: Routine 90-day prescriptions reduce the frequency of pharmacy visits and stock-out risk. Patients refill 75% less often, reducing the chances of encountering a stock gap.

Recommend mail-order for maintenance therapy: For stable patients on long-term ezetimibe, directing them to their insurance plan's preferred mail-order pharmacy dramatically reduces access issues.

Educate your care team: Train MAs and coordinators to direct ezetimibe access calls to the medfinder tool rather than escalating to the prescriber, reserving MD/NP time for cases where a prescription change is actually needed.

For statin-intolerant patients, document this clearly: Statin intolerance documentation in the chart expedites PA approvals for ezetimibe alternatives if supply gaps recur.

Patient Communication: What to Tell Patients

When patients call about not being able to find ezetimibe, recommend this simple script for your office staff:

"Ezetimibe is available at many pharmacies in your area. Your current pharmacy may just be temporarily out of stock. Try a nearby CVS, Walgreens, or Walmart pharmacy — they often have it in stock. You can also use medfinder (medfinder.com) to have pharmacies in your area checked for you. If you can't find it within a day or two, call us back and we'll discuss alternatives."

For more on the clinical shortage landscape, see Ezetimibe shortage: what providers and prescribers need to know in 2026.